surmount 2 tirzepatide once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide after intensive lifestyle intervention

The activation of TGR5 triggers the production of intracellular cAMP and secondary active the mitogen activated protein kinase signaling pathway to perform different functions in various organs

However, it is difficult to determine which is better without comparing the two directly under the same experimental conditions, like in this study

The reports of increased residual gastric content after long-term treatment with GLP-1 analogues emphasize that the effect on gastric emptying is sustained, even though that it does normally not pose a risk for postoperative respiratory complications [20]

Ozempic (semaglutide) activates GLP-1 receptors throughout the gut, causing delayed gastric emptying that reduces hunger but may also affect existing IBS symptoms in unpredictable ways